Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke
Conditions: Ischemic Stroke Interventions: Drug: Mongolian Medicine ZhenBao Pills; Drug: Mongolian Medicine ZhenBao Pills Placebo Sponsors: Dongzhimen Hospital, Beijing Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Conditions:   Connective Tissue Diseases;   Thrombocytopenia Interventions:   Biological: Telitacicept;   Drug: Placebo Sponsors:   Beijing Hospital;   The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial);   Peking University People's Hospital;   Peking University Third Hospital;   First Affiliated Hospital, Sun Yat-Sen University;   Guangdong Provincial People's  Hospital;   The First Affiliated Hospital of Zhengzhou University;   Wuhan Union Hospital, China;   Second Xiangya Hospital of Central South University;   Xiangya Hospital of Central...
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
Condition:   Gastrointestinal Neoplasm Malignant Interventions:   Other: Clinician-Directed Treatment Plan;   Other: ChatGPT-Assisted Treatment Plan Sponsors:   Chinese Academy of Sciences;   ZhuHai Hospital;   Fifth Affiliated Hospital, Sun Yat-Sen University;   Jiangmen Central Hospital;   Peking University Cancer Hospital (Inner Mongolia Campus);   San Raffaele University Hospital, Italy;   University Hospital Magdeburg, Germa ny;   Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Conditions:   Connective Tissue Diseases;   Thrombocytopenia Interventions:   Biological: Telitacicept;   Drug: Placebo Sponsors:   Beijing Hospital;   The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial);   Peking University People's Hospital;   Peking University Third Hospital;   First Affiliated Hospital, Sun Yat-Sen University;   Guangdong Provincial People's  Hospital;   The First Affiliated Hospital of Zhengzhou University;   Wuhan Union Hospital, China;   Second Xiangya Hospital of Central South University;   Xiangya Hospital of Central...
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
Condition:   Gastrointestinal Neoplasm Malignant Interventions:   Other: Clinician-Directed Treatment Plan;   Other: ChatGPT-Assisted Treatment Plan Sponsors:   Chinese Academy of Sciences;   ZhuHai Hospital;   Fifth Affiliated Hospital, Sun Yat-Sen University;   Jiangmen Central Hospital;   Peking University Cancer Hospital (Inner Mongolia Campus);   San Raffaele University Hospital, Italy;   University Hospital Magdeburg, Germa ny;   Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Conditions:   Connective Tissue Diseases;   Thrombocytopenia Interventions:   Biological: Telitacicept;   Drug: Placebo Sponsors:   Beijing Hospital;   The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial);   Peking University People's Hospital;   Peking University Third Hospital;   First Affiliated Hospital, Sun Yat-Sen University;   Guangdong Provincial People's  Hospital;   The First Affiliated Hospital of Zhengzhou University;   Wuhan Union Hospital, China;   Second Xiangya Hospital of Central South University;   Xiangya Hospital of Central...
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
Condition:   Gastrointestinal Neoplasm Malignant Interventions:   Other: Clinician-Directed Treatment Plan;   Other: ChatGPT-Assisted Treatment Plan Sponsors:   Chinese Academy of Sciences;   ZhuHai Hospital;   Fifth Affiliated Hospital, Sun Yat-Sen University;   Jiangmen Central Hospital;   Peking University Cancer Hospital (Inner Mongolia Campus);   San Raffaele University Hospital, Italy;   University Hospital Magdeburg, Germa ny;   Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Conditions:   Connective Tissue Diseases;   Thrombocytopenia Interventions:   Biological: Telitacicept;   Drug: Placebo Sponsors:   Beijing Hospital;   The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial);   Peking University People's Hospital;   Peking University Third Hospital;   First Affiliated Hospital, Sun Yat-Sen University;   Guangdong Provincial People's  Hospital;   The First Affiliated Hospital of Zhengzhou University;   Wuhan Union Hospital, China;   Second Xiangya Hospital of Central South University;   Xiangya Hospital of Central...
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
Condition:   Gastrointestinal Neoplasm Malignant Interventions:   Other: Clinician-Directed Treatment Plan;   Other: ChatGPT-Assisted Treatment Plan Sponsors:   Chinese Academy of Sciences;   ZhuHai Hospital;   Fifth Affiliated Hospital, Sun Yat-Sen University;   Jiangmen Central Hospital;   Peking University Cancer Hospital (Inner Mongolia Campus);   San Raffaele University Hospital, Italy;   University Hospital Magdeburg, Germa ny;   Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Conditions:   Connective Tissue Diseases;   Thrombocytopenia Interventions:   Biological: Telitacicept;   Drug: Placebo Sponsors:   Beijing Hospital;   The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial);   Peking University People's Hospital;   Peking University Third Hospital;   First Affiliated Hospital, Sun Yat-Sen University;   Guangdong Provincial People's  Hospital;   The First Affiliated Hospital of Zhengzhou University;   Wuhan Union Hospital, China;   Second Xiangya Hospital of Central South University;   Xiangya Hospital of Central...
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
Condition:   Gastrointestinal Neoplasm Malignant Interventions:   Other: Clinician-Directed Treatment Plan;   Other: ChatGPT-Assisted Treatment Plan Sponsors:   Chinese Academy of Sciences;   ZhuHai Hospital;   Fifth Affiliated Hospital, Sun Yat-Sen University;   Jiangmen Central Hospital;   Peking University Cancer Hospital (Inner Mongolia Campus);   San Raffaele University Hospital, Italy;   University Hospital Magdeburg, Germa ny;   Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials